Table 1. Baseline prevalence and annual incidence (one year follow-up) of Leishmania seropositivity in surveyed children.
| Study area | Prevalencea | Incidence | ||
| N positive at baseline/N total at baseline (%) | 95% CIb | N positive at follow up and negative at baseline/N negative at baseline (%) | 95% CIb | |
| Vake | 95/1520 (6.25) | (5.06–7.70) | 110/1388 (7.93) | (6.26–9.99) |
| Mtatsminda | 211/1995 (10.58) | (9.17–12.17) | 92/1777 (5.18) | (4.02–6.64) |
| Krtsanisi | 4/735 (0.54) | (0.21–1.44) | 33/731 (4.51) | (3.11–6.52) |
| Total (all districts) | 310/4250 (7.29) | (6.48–8.20) | 235/3896 (6.03) | (5.15–7.05) |
a
Prevalence estimates do not include two children with active form of VL detected during the study.
b
95% confidence interval calculated using GEE methods to account for within family correlation.